文献速递妇科

上皮性卵巢癌腹股沟淋巴结转移是否应归为IVB期

Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB?
PubMed 文献 · Gynecol Oncol · 2017-07-14

基于监测、流行病学和最终结果数据库(2004-2013年)的11,152例上皮性卵巢癌女性,比较因腹股沟淋巴结转移归为IV期(组1,n=151)与III期盆腔/腹主动脉旁淋巴结阳性(组2,n=4,403)、IV期远处淋巴结阳性(组3,n=642)及IV期远处转移(组4,n=5,956)的生存。组1五年总生存率为46.3%,与组2的44.9%无显著差异(p=0.4),高于组3的32.9%(p<0.001)和组4的25.3%(p<0.001)。作者认为这些患者不应重新分类为IVB期。

要点

  • 腹股沟淋巴结转移的卵巢癌患者五年总生存率为46.3%,与III期淋巴结阳性者的44.9%无显著差异(p=0.4)。
  • 腹股沟淋巴结转移者的五年总生存率高于远处淋巴结阳性者的32.9%(p<0.001)和远处转移者的25.3%(p<0.001)。
  • 作者认为,仅因腹股沟淋巴结转移而将患者归为IVB期的重新分类缺乏生存证据支持。

核心结论

  • 仅因腹股沟淋巴结转移而归为IV期的卵巢癌患者,其生存与盆腔/腹主动脉旁淋巴结受累者相似,且优于远处转移者。
  • 作者认为这些患者不应被重新分类为IVB期。

研究设计与样本

  • 回顾性队列研究,数据来自监测、流行病学和最终结果数据库(2004-2013年),共纳入11,152例上皮性卵巢癌女性。
  • 分组:组1为因腹股沟淋巴结阳性归为IV期(n=151);组2为III期伴腹主动脉旁/盆腔淋巴结阳性(n=4,403);组3为IV期伴远处淋巴结阳性(n=642);组4为IV期伴远处转移(n=5,956)。
  • 采用Kaplan-Meier法评估总生存率和癌症特异性生存率,采用对数秩检验和Cox风险模型进行单变量和多变量生存分析。

主要发现

  • 组1(n=151)五年总生存率为46.3%,组2(n=4,403)为44.9%,两组比较p=0.4。
  • 组1五年总生存率46.3% vs 组3(n=642)32.9%,p<0.001;组1 vs 组4(n=5,956)25.3%,p<0.001。
  • 控制年龄、种族和组织学类型后,组1的总死亡率和癌症特异性死亡率优于组3和组4,但与组2无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: According to the revised FIGO staging system women with ovarian carcinoma and inguinal lymph node (LN) metastases, formerly stage III, are now considered stage IVB. In this study we compare their survival to that of women with stage III and stage IV disease. METHODS: Women diagnosed with epithelial ovarian carcinoma were drawn from the Surveillance, Epidemiology, and End Results database (2004-2013). Four groups were formed: group 1 (stage IV due to positive inguinal nodes), group 2 (stage III with positive para-aortic/pelvic nodes), group 3 (stage IV with positive distant nodes) and group 4 (stage IV with distant metastases). Overall (OS) and cancer-specific survival (CSS) rates were evaluated with the Kaplan-Meier method. The log-rank test and Cox-hazard models were employed for univariate and multivariate survival analysis. RESULTS: A total of 11,152 women were identified. Five-year OS for women in group 1 (n=151) was 46.3% compared to 44.9% for those in group 2 (n=4,403) (p=0.4), 32.9% in group 3 (n=642) (p<0.001) and 25.3% in group 4 (n=5,956) (p<0.001). After controlling for age, race and histology, group 1 had improved overall and cancer-specific mortality compared to groups 3 and 4 but not group 2. CONCLUSIONS: Ovarian cancer patients with stage IV ovarian cancer due solely to inguinal nodal metastases have similar survival as those with pelvic/para-aortic nodal involvement and improved survival compared to those harboring distant metastases. Our findings do not support the reclassification of these patients as stage IVB.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Nasioudis D, Chapman-Davis E, Frey MK, et al. Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB? Gynecol Oncol. 2017. PMID: 28716307. doi:10.1016/j.ygyno.2017.07.124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。